402 related articles for article (PubMed ID: 1225069)
1. [Substitution therapy of hemorrhagic diseases].
Haupt H
Anasthesiol Intensivmed Prax; 1975 Oct; 11(1):137-44. PubMed ID: 1225069
[No Abstract] [Full Text] [Related]
2. [Blood plasma fractions for the management of coagulation disorders: 3. The P.P.S.B. fraction].
Richter K; Klingenberg K; Reinecke D
Z Gesamte Inn Med; 1968 Jan; 23(1):18-21. PubMed ID: 5662427
[No Abstract] [Full Text] [Related]
3. [Substitution treatment in hemophilia. Critical measures and complications].
Schimpf K
Wien Med Wochenschr; 1977 Jun; 127(11):329-37. PubMed ID: 878496
[No Abstract] [Full Text] [Related]
4. [Principles of modern therapy for hemophilia A and B in childhood].
Ströder J; Ambs E
Dtsch Med Wochenschr; 1968 Mar; 93(12):539-41. PubMed ID: 5639667
[No Abstract] [Full Text] [Related]
5. Substitution treatment of hemophilia a and b.
Duckert F
Schweiz Med Wochenschr; 1975 Jun; 105(24):783-4. PubMed ID: 1145162
[TBL] [Abstract][Full Text] [Related]
6. Transfusion support for haemophiliacs.
Allain JP
Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835
[No Abstract] [Full Text] [Related]
7. Editorial: Factor VIII inhibitors.
Deykin D
N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491
[No Abstract] [Full Text] [Related]
8. Activated prothrombin concentrate for patients with factor VIII inhibitors.
Kurczynski EM; Penner JA
N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
[No Abstract] [Full Text] [Related]
9. Surgical care of patients with hereditary disorders of blood coagulation.
Shulman NR
Mod Treat; 1968 Jan; 5(1):61-83. PubMed ID: 4870180
[No Abstract] [Full Text] [Related]
10. [The treatment of inherited coagulation disorders].
Blombäck M; Nilsson IM
Lakartidningen; 1972 Dec; 69():Suppl 4:76-84. PubMed ID: 4540328
[No Abstract] [Full Text] [Related]
11. Surgery in haemophilic patients with inhibitors.
Rodriguez-Merchan EC
Haemophilia; 2004 Sep; 10 Suppl 2():1-2. PubMed ID: 15385039
[No Abstract] [Full Text] [Related]
12. Induction of immune tolerance in hemophiliacs with inhibitors by combined treatment with i.v. IgG, cyclophosphamide and factor VIII or IX.
Nilsson IM; Berntorp E
Prog Clin Biol Res; 1990; 324():69-78. PubMed ID: 2106694
[No Abstract] [Full Text] [Related]
13. The use of blood fractions in coagulation disorders.
Biggs R
Br J Haematol; 1969 Dec; 17(6):604. PubMed ID: 5357747
[No Abstract] [Full Text] [Related]
14. [Advances in the field of hemophilia therapy].
Loeliger EA; Veltkamp JJ
Ned Tijdschr Geneeskd; 1968 Sep; 112(36):1593-5. PubMed ID: 5680135
[No Abstract] [Full Text] [Related]
15. [Substitution therapy of coagulopathies].
Beeser H; Egli H
Infusionstherapie (1973); 1974 Aug; 1(6):447-53. PubMed ID: 4466806
[No Abstract] [Full Text] [Related]
16. Hemophilia and prophylaxis.
Ljung R
Pediatr Blood Cancer; 2013; 60 Suppl 1():S23-6. PubMed ID: 23109472
[TBL] [Abstract][Full Text] [Related]
17. [Concentrated antihemophilic globulin in the treatment of hemorrhagic syndromes].
Baklaja F; Cvetković V; Stajić M; Krivokapić L
Bilt Hematol Transfuz; 1976; 4(3):61-6. PubMed ID: 1008799
[TBL] [Abstract][Full Text] [Related]
18. [Substitution therapy with factor 8 and factor IX preparations].
Landbeck G
Hamatol Bluttransfus; 1968; 5():29-42. PubMed ID: 5729465
[No Abstract] [Full Text] [Related]
19. [Coagulation factors. Indications and applications].
Stampfli K; Hartmann S
Ther Umsch; 1984 Aug; 41(8):571-5. PubMed ID: 6437000
[No Abstract] [Full Text] [Related]
20. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]